Approval · Notice of Compliance 23093 · 2020
BILTRICIDE: Notice of Compliance 23093
Issued January 8, 2020
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 23093
- Date
- January 8, 2020
- Company
- Bayer Inc.Elkhart, Indiana, United States
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Labelling Only
- Reason
- To update label design elements due to a primary and secondary packaging site change
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| BILTRICIDE | Not yet assigned | — |
Medicinal ingredients
- PRAZIQUANTEL 600 MG per TAB